Covariates | Overall survival HR (95%CI) | p Value |
---|---|---|
Age (< 65 vs. ≥ 65) | 1.288 (0.904–1.834) | 0.161 |
Gender (female vs. male) | 1.183 (0.823–1.7) | 0.363 |
BMI (< 25 vs. ≥ 25) | 1.146 (0.792–1.659) | 0.470 |
Histological grade | ||
 G1 | 1 |  |
 G2 | 1.137 (0.67–1.93) | 0.634 |
 G3 | 1.202 (0.689–2.095) | 0.517 |
 G4 | 1.641 (0.606–4.442) | 0.33 |
Clinical stage | ||
 Stage I/II | 1 |  |
 Stage III/IV | 2.463 (1.691–3.589) |  < 0.001 |
T stage | ||
 T1/2 | 1 |  |
 T3/4 | 2.594 (1.813–3.710) |  < 0.001 |
AFP (< 300 vs. ≥ 300) | 1.018 (0.615–1.685) | 0.945 |
Vascular invasion | ||
 None | 1 |  |
 Mico | 0.833 (0.519–1.337) | 0.449 |
 Macro | 1.284 (0.516–3.193) | 0.591 |
Risk (high vs. low) | 2.723 (1.874–3.956) |  < 0.001 |